Patents Assigned to Sunbird Bio, Inc.
  • Patent number: 12492422
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Grant
    Filed: January 11, 2022
    Date of Patent: December 9, 2025
    Assignee: Sunbird Bio, Inc.
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer